Consolidated Statement Of Cash Flows

Takeda Pharmaceutical Company Limited - Filing #7251660

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
107,928,000,000 JPY
107,928,000,000 JPY
215,000,000 JPY
108,143,000,000 JPY
144,067,000,000 JPY
144,067,000,000 JPY
144,197,000,000 JPY
JPY
130,000,000 JPY
Depreciation and amortization
761,396,000,000 JPY
728,002,000,000 JPY
Impairment losses (reversal of impairment losses)
106,529,000,000 JPY
150,017,000,000 JPY
Share of loss (profit) of investments accounted for using equity method
3,986,000,000 JPY
-6,473,000,000 JPY
Income tax expense
66,941,000,000 JPY
-91,406,000,000 JPY
Decrease (increase) in inventories
-34,973,000,000 JPY
-115,743,000,000 JPY
Increase (decrease) in provisions
45,166,000,000 JPY
-126,901,000,000 JPY
Other
-10,107,000,000 JPY
-7,556,000,000 JPY
Income taxes paid
-170,589,000,000 JPY
-219,941,000,000 JPY
Net cash provided by (used in) operating activities
1,057,182,000,000 JPY
716,344,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-200,795,000,000 JPY
-175,420,000,000 JPY
Proceeds from sale of property, plant and equipment
78,000,000 JPY
8,606,000,000 JPY
Purchase of intangible assets
-147,046,000,000 JPY
-305,310,000,000 JPY
Other
-1,111,000,000 JPY
-4,003,000,000 JPY
Net cash provided by (used in) investing activities
-367,060,000,000 JPY
-463,862,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-51,860,000,000 JPY
-2,326,000,000 JPY
Dividends paid
-302,498,000,000 JPY
-287,188,000,000 JPY
Other
-16,647,000,000 JPY
-26,102,000,000 JPY
Net cash provided by (used in) financing activities
-751,425,000,000 JPY
-354,416,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-61,303,000,000 JPY
-101,934,000,000 JPY
Cash and cash equivalents
385,113,000,000 JPY
457,800,000,000 JPY
533,530,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-11,385,000,000 JPY
26,204,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.